SLC2A13-ARHGDIB Fusion FISH Probe
The SLC2A13-ARHGDIB Fusion FISH Probe is used to confirm a fusion of the SLC2A13 and ARHGDIB genes. The fusion of the SLC2A13 and ARHGDIB genes has been associated with Sarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SLC2A13-ARHGDIB-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SLC2A13-ARHGDIB-20-AQAQ | 20 (40 μL) | 200 μL |
|
ARHGDIB Gene Summary
Members of the Rho (or ARH) protein family (see MIM 165390) and other Ras-related small GTP-binding proteins (see MIM 179520) are involved in diverse cellular events, including cell signaling, proliferation, cytoskeletal organization, and secretion. The GTP-binding proteins are active only in the GTP-bound state. At least 3 classes of proteins tightly regulate cycling between the GTP-bound and GDP-bound states: GTPase-activating proteins (GAPs), guanine nucleotide-releasing factors (GRFs), and GDP-dissociation inhibitors (GDIs). The GDIs, including ARHGDIB, decrease the rate of GDP dissociation from Ras-like GTPases (summary by Scherle et al., 1993 [PubMed 8356058]).[supplied by OMIM, Dec 2010]
Gene Name: Rho GDP Dissociation Inhibitor Beta
Chromosome: CHR12: 15094949 -15114562
Locus: 12p12.3
SLC2A13 Gene Summary
The Solute Carrier Family 2 Member 13 (SLC2A13) gene is located on chr12 :40148822-40499661 at 12q12.
Gene Name: Solute Carrier Family 2 Member 13
Chromosome: CHR12: 40148822 -40499661
Locus: 12q12
Gene Diseases
The SLC2A13 ARHGDIB Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Sarcoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|